Additional file 2: of Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Capasso, A.; Lang, J.; Pitts, T.; Jordan, K.; Lieu, C.; Davis, S.; Diamond, J.; Kopetz, S.; Barbee, J.; Peterson, J.; Freed, B.; Yacob, B.; Bagby, S.; Messersmith, W.; Slansky, J.; Pelanda, R.; Eckhardt, S.

doi:10.6084/m9.figshare.7698782.v1

40425_2019_518_MOESM2_ESM.docx (20.14 kB)

Additional file 2: of Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

journal contribution

posted on 2019-02-08, 05:00 authored by A. Capasso, J. Lang, T. Pitts, K. Jordan, C. Lieu, S. Davis, J. Diamond, S. Kopetz, J. Barbee, J. Peterson, B. Freed, B. Yacob, S. Bagby, W. Messersmith, J. Slansky, R. Pelanda, S. Eckhardt

Table S1. Experimental details and timeline for tumor growth studies in BRGS and hu-CB-BRGS mice. (DOCX 20 kb)

Funding

Cancer League of Colorado

History

Usage metrics

Keywords

Humanized mice Immunotherapy Nivolumab Combination Pre-clinical PDX CRC TNBC

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

Funding

Cancer League of Colorado

History

Usage metrics

Categories

Keywords

Licence

Exports